Financial Gravity Asset Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Financial Gravity Asset Management’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-56	Closed	-$1K	–	1733
2019 Q2	$1K	Sell	56 -9	-14%	-$171	﹤0.01%	1196
2019 Q1	$1K	Buy	+65	New	+$1.05K	﹤0.01%	1296
2018 Q3	$1K	Buy	+68	New	+$680	﹤0.01%	1353

Financial Gravity Asset Management's OSIR Position: Q3 2019 in Review

Financial Gravity Asset Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q3 2019, closing a stake of 56 shares — an estimated $1K sold.

Financial Gravity Asset Management first reported a position in OSIR in Q3 2018 and held it in 3 quarters. The position peaked at $1K in Q2 2019. 0 funds tracked by Wall St. Rank hold OSIR as of Q3 2019.

Financial Gravity Asset Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Financial Gravity Asset Management sold 56 Osiris Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $1K.
Financial Gravity Asset Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2018 and held it in 3 quarters.
Financial Gravity Asset Management's Osiris Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2019.
0 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Financial Gravity Asset Management's 13F filing for Q3 2019, filed 15 Oct 2019.